Alan Huang

2022

In 2022, Alan Huang earned a total compensation of $1.8M as Chief Scientific Officer at Tango Therapeutics, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$193,550
Option Awards$1,197,000
Salary$425,385
Other$2,966
Total$1,818,901

Huang received $1.2M in option awards, accounting for 66% of the total pay in 2022.

Huang also received $193.6K in non-equity incentive plan, $425.4K in salary and $3K in other compensation.

Rankings

In 2022, Alan Huang's compensation ranked 1,908th out of 5,753 executives tracked by ExecPay. In other words, Huang earned more than 66.8% of executives.

ClassificationRankingPercentile
All
1,908
out of 5,753
67th
Division
Manufacturing
1,014
out of 3,133
68th
Major group
Chemicals And Allied Products
427
out of 1,419
70th
Industry group
Drugs
392
out of 1,320
70th
Industry
Pharmaceutical Preparations
282
out of 966
71st
Source: SEC filing on April 24, 2023.

Huang's colleagues

We found two more compensation records of executives who worked with Alan Huang at Tango Therapeutics in 2022.

2022

Barbara Weber

Tango Therapeutics

Chief Executive Officer

2022

Daniella Beckman

Tango Therapeutics

Chief Financial Officer

News

In-depth

You may also like